{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-080896","form_type":"8-K","ticker":"KYTX","cik":"0001994702","company_name":"Kyverna Therapeutics, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.654142+00:00","generated_at":"2026-05-20T02:01:44.089703+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Kyverna Therapeutics shareholders elect two Class I directors and ratify BDO as auditor at 2025 Annual Meeting","bullets":["30,546,469 shares (70.67% of outstanding) represented at May 29, 2025 Annual Meeting.","Beth Seidenberg, M.D. elected with 18,161,970 votes for, 2,508,848 withheld.","Fred E. Cohen, M.D., D. Phil. elected with 18,513,181 votes for, 2,157,637 withheld.","Ratification of BDO USA, P.C. as auditor for 2025 passed with 30,374,716 for, 142,212 against, 29,541 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-080896","json":"https://secwatch.observer/filing/0000950170-25-080896.json","markdown":"https://secwatch.observer/filing/0000950170-25-080896.md","text":"https://secwatch.observer/filing/0000950170-25-080896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/0000950170-25-080896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/kytx-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:01:44.089703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}